Affordable Access

deepdyve-link
Publisher Website

Liver transplantation for acute liver failure due to efavirenz hepatotoxicity: the importance of routine monitoring.

Authors
  • Fink, Douglas L
  • Bloch, Edward
Type
Published Article
Journal
International Journal of STD & AIDS
Publisher
SAGE Publications
Publication Date
Oct 01, 2013
Volume
24
Issue
10
Pages
831–833
Identifiers
DOI: 10.1177/0956462413483720
PMID: 23970595
Source
Medline
Keywords
License
Unknown

Abstract

We present the first case report in the UK of acute liver failure caused by efavirenz therapy culminating in liver transplantation. A 26-year-old Zimbabwean woman commenced emtricitabine, tenofovir and efavirenz (Atripla) in December 2011. Her liver function tests at baseline and at 20 days after initiating antiretroviral therapy were normal. At three months of therapy her blood tests haemolysed and were not processed. She had previously missed follow-up appointments and on this occasion failed to return for repeat tests. She was not seen again until after six months of antiretroviral therapy when she presented to her general practitioner with acute liver failure. Her condition deteriorated and she required liver transplantation. She recovered well and re-started antiretroviral therapy to good effect. The case illustrates the value of routine monitoring after initiating antiretroviral therapy and the fundamental importance of engaging patients in long-term management to ensure safe treatment.

Report this publication

Statistics

Seen <100 times